Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1998 Feb;82(2):162-7.
doi: 10.1136/bjo.82.2.162.

Effect of isovolaemic haemodilution on visual outcome in branch retinal vein occlusion

Affiliations
Clinical Trial

Effect of isovolaemic haemodilution on visual outcome in branch retinal vein occlusion

H C Chen et al. Br J Ophthalmol. 1998 Feb.

Abstract

Aims: To assess the efficacy of isovolaemic haemodilution therapy (IHT) in the treatment of patients with branch retinal vein occlusion (BRVO).

Methods: Patients presenting with BRVO between 1 July 1991 and 31 August 1993 were eligible for inclusion and randomised into treatment and control groups. Patients randomised to receive IHT were treated for 6 weeks with venesection and volume replacement using hydroxyethylstarch, a plasma expander. The target haematocrit was 35%. Follow up was for 1 year.

Results: The baseline visual acuity of the two groups was similar at 0.74 and 0.75 logMAR units (Snellen 6/36), for the IHT and control groups, respectively. At 6 weeks, visual acuity in the IHT group had improved by 0.20 logMAR units (2 lines on the Bailey-Lovie chart) (p = 0.0001). Vision was unchanged in the control group. At 1 year, the IHT group exhibited an improvement of 0.43 logMAR units. By comparison, the improvement in the control group at 1 year was significantly less at 0.17 logMAR units (p = 0.03). The final visual acuity in the IHT and control groups was 0.30 (Snellen 6/12) and 0.60 (Snellen 6/24) logMAR units, respectively.

Conclusions: The results support the theory that IHT has a positive effect on the visual outcome in patients with BRVO.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mean visual acuity. Each point shows the mean visual acuity (vertical bars, mean (SEM)) in both groups of patients from entry into the study to 1 year. The visual acuity is presented in logMAR units; a decreasing value indicates an improving visual acuity. The p value at which the difference between the two groups reaches statistical significance is shown.
Figure 2
Figure 2
(A) Visual acuity at 6 weeks. This presents the visual acuity at entry into the study and at 6 weeks. Values on the diagonal line are those experiencing no change; those above the line improved and those below deteriorated. (B) Visual acuity at 1 year. This presents the visual acuity at entry into the study and at 1 year. Values on the diagonal line are those experiencing no change; those above the line improved and those below deteriorated.

References

    1. J Appl Physiol. 1967 Mar;22(3):501-4 - PubMed
    1. Arch Ophthalmol. 1992 Oct;110(10):1427-34 - PubMed
    1. Am J Ophthalmol. 1970 May;69(5):778-825 - PubMed
    1. Br Med Bull. 1970 May;26(2):143-50 - PubMed
    1. Br J Ophthalmol. 1974 May;58(5):548-54 - PubMed

Publication types

Substances